UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The potential of biologics for the treatment of asthma

Nature reviews. Drug discovery, 2012-12, Vol.11 (12), p.958-972

2012

Volltextzugriff (PDF)

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

Mediators of Inflammation, 2015-01, Vol.2015 (2015), p.690-697-465

2015

Volltextzugriff (PDF)

Asthma: Targeted Biological Therapies

1st ed. 2017 edition., 2016

Volltextzugriff (PDF)

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments

Current drug targets, 2015-01, Vol.16 (2), p.171-178

2015

Volltextzugriff (PDF)

Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma

Respiratory medicine, 2008-08, Vol.102 (8), p.1173-1181

2008

Volltextzugriff (PDF)

Alpha-interferon and its effects on signal transduction pathways

Journal of cellular physiology, 2005-02, Vol.202 (2), p.323-335

2005

Volltextzugriff (PDF)

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems

Therapeutic Advances in Respiratory Disease, 2008-12, Vol.2 (6), p.409-421

2008

Volltextzugriff (PDF)

Dupilumab for the treatment of asthma

Expert opinion on biological therapy, 2017-12, Vol.17 (12), p.1565-1572

2017

Volltextzugriff (PDF)

Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ETA receptor-dependent activation of map kinases

Journal of cellular biochemistry, 2005-11, Vol.96 (4), p.858-868

2005

Volltextzugriff (PDF)

Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells

Journal of cellular biochemistry, 2004-09, Vol.93 (1), p.142-152

2004

Volltextzugriff (PDF)

Dupilumab: a novel treatment for asthma

Journal of asthma and allergy, 2014-01, Vol.7 (default), p.123-130

2014

Volltextzugriff (PDF)

Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma

Pulmonary pharmacology & therapeutics, 2016-10, Vol.40, p.15-21

2016

Volltextzugriff (PDF)

Update on Anticytokine Treatment for Asthma

BioMed research international, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Role of biologics in severe eosinophilic asthma - focus on reslizumab

Therapeutics and clinical risk management, 2016-01, Vol.12, p.1075-1082

2016

Volltextzugriff (PDF)

Application of Proteomics and Peptidomics to COPD

BioMed research international, 2014-01, Vol.2014 (2014), p.1-8

2014

Volltextzugriff (PDF)

Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment

Expert opinion on pharmacotherapy, 2015-09, Vol.16 (13), p.2009-2021

2015

Volltextzugriff (PDF)

Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium

Pharmacology, 2014-01, Vol.94 (5-6), p.249-258

2014

Volltextzugriff (PDF)

Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases

Proteomics (Weinheim), 2011-08, Vol.11 (16), p.3402-3414

2011

Volltextzugriff (PDF)

Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

Multidisciplinary respiratory medicine, 2014-12, Vol.9 (1), p.64-64, Article 64

2014

Volltextzugriff (PDF)

Asthma

1, 2016

Volltextzugriff (PDF)

Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

Multidisciplinary respiratory medicine, 2014-12, Vol.9

2014

Volltextzugriff (PDF)

Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β 2 -adrenergic agonist combinations in chronic obstructive pulmonary disease treatment

Expert opinion on pharmacotherapy, 2015-09, Vol.16 (13), p.2009-2021

2015

Volltextzugriff (PDF)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma

Clinical and molecular allergy CMA, 2017-04, Vol.15 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach

Drug design, development and therapy, 2017-01, Vol.11, p.265-272

2017

Volltextzugriff (PDF)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Therapeutics and clinical risk management, 2015-01, Vol.11 (default), p.1563-1572

2015

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Humans
(32)
Allergies
(16)
Asthma
(15)
Pharmacology
(14)
Respiratory Medicine
(12)
Chronic Obstructive Pulmonary Disease
(11)
Review
(11)
Pharmacology & Pharmacy
(10)
Respiratory System
(9)
Severe Asthma
(9)
Asthma - Drug Therapy
(8)
Health Aspects
(8)
Animals
(7)
Biological And Medical Sciences
(7)
Male
(7)
Bronchodilators
(6)
Cell Biology
(6)
Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The potential of biologics for the treatment of asthma

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

Asthma: Targeted Biological Therapies

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments

Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma

Alpha-interferon and its effects on signal transduction pathways

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems

Dupilumab for the treatment of asthma

Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ETA receptor-dependent activation of map kinases

Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells

Dupilumab: a novel treatment for asthma

Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma

Update on Anticytokine Treatment for Asthma

Role of biologics in severe eosinophilic asthma - focus on reslizumab

Application of Proteomics and Peptidomics to COPD

Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment

Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium

Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases

Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

Asthma

Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β 2 -adrenergic agonist combinations in chronic obstructive pulmonary disease treatment

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma

Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Suchergebnisse filtern